Insiders · Profile

Albright Charles

EVP/Chief Scientific Officer at Editas Medicine. Filing since 23 May 2018. CIK 0001682323

Company

Date

Role

Action

Shares

Amount

Of holding

EDIT Editas Medicine, Inc.

15 Dec 2020

EVP/Chief Scientific Officer

Sold, plan not stated

10,000

$632.16K

28.6%

EDIT Editas Medicine, Inc.

9 Dec 2020

EVP/Chief Scientific Officer

Sold, plan not stated

10,000

$450.00K

28.6%

EDIT Editas Medicine, Inc.

7 Dec 2020

EVP/Chief Scientific Officer

Sold, plan not stated

20,000

$800.40K

44.5%

EDIT Editas Medicine, Inc.

9 Nov 2020

EVP/Chief Scientific Officer

Sold, plan not stated

228

$7.12K

0.9%

EDIT Editas Medicine, Inc.

15 Oct 2020

EVP/Chief Scientific Officer

Sold, plan not stated

3,000

$94.17K

10.7%

EDIT Editas Medicine, Inc.

17 Aug 2020

EVP/Chief Scientific Officer

Sold, plan not stated

10,000

$352.90K

26.2%

EDIT Editas Medicine, Inc.

7 Aug 2020

EVP/Chief Scientific Officer

Sold, plan not stated

238

$8.33K

0.8%

EDIT Editas Medicine, Inc.

6 Aug 2020

EVP/Chief Scientific Officer

Sold, plan not stated

10,000

$374.70K

26.1%

EDIT Editas Medicine, Inc.

15 Jul 2020

EVP/Chief Scientific Officer

Sold, plan not stated

3,000

$96.66K

9.6%

EDIT Editas Medicine, Inc.

6 May 2020

EVP/Chief Scientific Officer

Sold, plan not stated

151

$3.82K

0.5%

EDIT Editas Medicine, Inc.

7 Feb 2020

Chief Scientific Officer

Sold, plan not stated

622

$16.76K

1.9%

EDIT Editas Medicine, Inc.

3 Feb 2020

Chief Scientific Officer

Sold, plan not stated

5,549

$147.29K

21.3%

EDIT Editas Medicine, Inc.

13 Jun 2018

Chief Scientific Officer

Sold, plan not stated

10,000

$359.80K

100%

EDIT Editas Medicine, Inc.

23 May 2018

Chief Scientific Officer

Sold, plan not stated

10,000

$350.00K

100%

14 decisions on file.